These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38880199)

  • 61. Generalized pustular psoriasis rapidly and successfully treated with ixekizumab in a Caucasian patient.
    Megna M; Abategiovanni L; Annunziata A; Torta G; Peduto T; Fabbrocini G; Lauro W
    Dermatol Ther; 2022 May; 35(5):e15382. PubMed ID: 35170168
    [No Abstract]   [Full Text] [Related]  

  • 62. Combination therapy of infliximab and granulocyte/monocyte adsorption apheresis for refractory pustular psoriasis with psoriatic arthritis.
    Fujisawa T; Moriya C; Shibuya Y; Kanoh H; Seishima M
    Acta Derm Venereol; 2013 May; 93(3):364-5. PubMed ID: 23007291
    [No Abstract]   [Full Text] [Related]  

  • 63. The efficacy of ixekizumab treatment in Chinese psoriasis patients: a short-term retrospective study.
    Yao X; Yuan J; Zhang Y; Li Y
    Eur J Dermatol; 2024 Apr; 34(2):176-181. PubMed ID: 38907548
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical analysis of generalized pustular psoriasis in Chinese patients: A retrospective study of 110 patients.
    Zheng J; Chen W; Gao Y; Chen F; Yu N; Ding Y; Liu N
    J Dermatol; 2021 Sep; 48(9):1336-1342. PubMed ID: 34018629
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis.
    Majima Y; Yagi H; Tateishi C; Groth S; Schmidt E; Zillikens D; Koga H; Hashimoto T; Tokura Y
    Br J Dermatol; 2013 Jun; 168(6):1367-9. PubMed ID: 23252972
    [No Abstract]   [Full Text] [Related]  

  • 66. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
    Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
    Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational Study.
    Li Y; Dang L; Lv C; Lin B; Tao J; Yu N; Deng Y; Wang H; Kang X; Qin H; Chen R; Li J; Liang Y; Liang Y; Shi Y
    Drug Saf; 2024 Jul; 47(7):711-719. PubMed ID: 38689136
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis.
    Bachelez H; Choon SE; Marrakchi S; Burden AD; Tsai TF; Morita A; Turki H; Hall DB; Shear M; Baum P; Padula SJ; Thoma C
    N Engl J Med; 2019 Mar; 380(10):981-983. PubMed ID: 30855749
    [No Abstract]   [Full Text] [Related]  

  • 69. Generalized pustular psoriasis-Dawn of a new era in targeted immunotherapy.
    Neuhauser R; Eyerich K; Boehner A
    Exp Dermatol; 2020 Nov; 29(11):1088-1096. PubMed ID: 32780422
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab.
    Mehta H; Mashiko S; Angsana J; Rubio M; Hsieh YM; Maari C; Reich K; Blauvelt A; Bissonnette R; Muñoz-Elías EJ; Sarfati M
    J Invest Dermatol; 2021 Jul; 141(7):1707-1718.e9. PubMed ID: 33524368
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study.
    Lee MG; Huang YH; Lee JH; Lee SC; Kim TG; Aw DC; Bao W; Dee CMA; Guana A; Tsai TF
    J Dermatol; 2019 Sep; 46(9):752-758. PubMed ID: 31342560
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapid response of pityriasis rubra pilaris with psoriasis overlap to secukinumab.
    Cole D; Mohammad T; Lim H
    Br J Dermatol; 2019 Dec; 181(6):1331-1332. PubMed ID: 31260082
    [No Abstract]   [Full Text] [Related]  

  • 73. Successful treatment with adalimumab in a patient with psoriatic arthritis and generalized pustular psoriasis.
    Kimura U; Kinoshita A; Sekigawa I; Takamori K; Suga Y
    J Dermatol; 2012 Dec; 39(12):1071-2. PubMed ID: 22506677
    [No Abstract]   [Full Text] [Related]  

  • 74. Remarkable response to ixekizumab in a patient with generalized pustular psoriasis: a therapeutic challenge.
    Hsu HH; Wang HJ; Sun Y; Lan CC
    Ital J Dermatol Venerol; 2024 Jun; 159(3):373-374. PubMed ID: 38635325
    [No Abstract]   [Full Text] [Related]  

  • 75. Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation.
    Hackley M; Thampy D; Waseh S; Feldman SR; Blauvelt A; Weinberg JM; Schwartzman S; Liao W; Prussick R; Cohen JM; Hsu S;
    J Am Acad Dermatol; 2024 Feb; 90(2):408-410. PubMed ID: 37821053
    [No Abstract]   [Full Text] [Related]  

  • 76. Current management of generalized pustular psoriasis.
    Kodali N; Blanchard I; Kunamneni S; Lebwohl MG
    Exp Dermatol; 2023 Aug; 32(8):1204-1218. PubMed ID: 36779681
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel Therapeutic Approaches and Targets for Treatment of Psoriasis.
    Radi G; Campanati A; Diotallevi F; Bianchelli T; Offidani A
    Curr Pharm Biotechnol; 2021; 22(1):7-31. PubMed ID: 32598253
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Real-world data on the clinical use of secukinumab in pediatric generalized pustular psoriasis: A 48-week retrospective study.
    Ruan SF; Zhang LL; Liu Z; Lin TT; Wang HQ; Xu QY; Xiang N; Cheng B; Liu T; Ha HY; Gong T; Ji C
    J Am Acad Dermatol; 2023 Jan; 88(1):243-246. PubMed ID: 35588923
    [No Abstract]   [Full Text] [Related]  

  • 79. Spesolimab: A Review of the First IL-36 Blocker Approved for Generalized Pustular Psoriasis.
    Pathak GN; Wang E; Dhillon J; Parikh PN; Esseghir R; Rao BK; Feldman SR
    Ann Pharmacother; 2024 May; ():10600280241252688. PubMed ID: 38755971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A review of disease burden and clinical management for generalized pustular psoriasis in China.
    Lu J; Shi Y
    Expert Rev Clin Immunol; 2022 Oct; 18(10):1023-1032. PubMed ID: 36040447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.